Lilly & Novo; American Express; Regional Banks Move Higher
On this episode of Stock Movers:- Shares of pharma giants Eli Lilly (LLY) and Novo Nordisk (NOVOB DC) are falling in premarket trading after President Trump said the price of the blockbuster diabetes drug Ozempic could come down to just $150 a month. The US list price of Ozempic is roughly $1,000 for a month’s supply. Trump told reporters on Thursday that the cost of the drug, made by Novo, will soon be “much lower.” Lilly sells similar treatments, including Mounjaro and Zepbound.- American Express (AXP) shares moved lower ahead of the US open after Amex reported earnings…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.